153 related articles for article (PubMed ID: 27333081)
1. A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs.
Zhu XY; Liu HC; Guo SY; Xia B; Song RS; Lao QC; Xuan YX; Li CQ
Zebrafish; 2016 Aug; 13(4):335-44. PubMed ID: 27333081
[TBL] [Abstract][Full Text] [Related]
2. A Zebrafish Heart Failure Model for Assessing Therapeutic Agents.
Zhu XY; Wu SQ; Guo SY; Yang H; Xia B; Li P; Li CQ
Zebrafish; 2018 Jun; 15(3):243-253. PubMed ID: 29653073
[TBL] [Abstract][Full Text] [Related]
3. Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish.
Zhu JJ; Xu YQ; He JH; Yu HP; Huang CJ; Gao JM; Dong QX; Xuan YX; Li CQ
J Appl Toxicol; 2014 Feb; 34(2):139-48. PubMed ID: 23307606
[TBL] [Abstract][Full Text] [Related]
4. Anti-thrombotic and pro-angiogenic effects of Rubia cordifolia extract in zebrafish.
Chen Y; Chen PD; Bao BH; Shan MQ; Zhang KC; Cheng FF; Cao YD; Zhang L; Ding AW
J Ethnopharmacol; 2018 Jun; 219():152-160. PubMed ID: 29126989
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Quality Marker (Q-Marker) of Danhong Injection by the Zebrafish Thrombosis Model.
Qi Y; Zhao X; Liu H; Wang Y; Zhao C; Zhao T; Zhao B; Wang Y
Molecules; 2017 Aug; 22(9):. PubMed ID: 28858254
[TBL] [Abstract][Full Text] [Related]
6. Rapid analysis of hypolipidemic drugs in a live zebrafish assay.
Zhou J; Xu YQ; Guo SY; Li CQ
J Pharmacol Toxicol Methods; 2015; 72():47-52. PubMed ID: 25497901
[TBL] [Abstract][Full Text] [Related]
7. Zebrafish model of photochemical thrombosis for translational research and thrombolytic screening in vivo.
Lee IJ; Yang YC; Hsu JW; Chang WT; Chuang YJ; Liau I
J Biophotonics; 2017 Apr; 10(4):494-502. PubMed ID: 27174426
[TBL] [Abstract][Full Text] [Related]
8. Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs.
Jagadeeswaran P; Cooley BC; Gross PL; Mackman N
Circ Res; 2016 Apr; 118(9):1363-79. PubMed ID: 27126647
[TBL] [Abstract][Full Text] [Related]
9. Human prokinetic drugs promote gastrointestinal motility in zebrafish.
Zhou J; Guo SY; Zhang Y; Li CQ
Neurogastroenterol Motil; 2014 Apr; 26(4):589-95. PubMed ID: 24533865
[TBL] [Abstract][Full Text] [Related]
10. Individualized antithrombotic therapy.
Lüscher TF; Steffel J
Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
[TBL] [Abstract][Full Text] [Related]
11. The arterial antithrombotic activity of thioxylosides in a rat model of laser-induced thrombosis.
Aguejouf O; Oualane FA; Inamo J; Imbault P; Doutremepuich F; Millet J; Theveniaux J; Doutremepuich C
Semin Thromb Hemost; 1996; 22(4):327-33. PubMed ID: 8944417
[TBL] [Abstract][Full Text] [Related]
12. Identification of cryptotanshinone from Tongmai to inhibit thrombosis in zebrafish via regulating oxidative stress and coagulation cascade.
Sheng J; Meng Q; Yang Z; Guan J; Zhao Y; Zhang J; Wang Y; Zhao L; Wang Y
Phytomedicine; 2020 Jun; 76():153263. PubMed ID: 32563016
[TBL] [Abstract][Full Text] [Related]
13. Current trends in antithrombotic drug and device development.
Fareed J
Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
[TBL] [Abstract][Full Text] [Related]
14. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY
Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321
[TBL] [Abstract][Full Text] [Related]
15. Lignans and aromatic glycosides from Piper wallichii and their antithrombotic activities.
Shi YN; Shi YM; Yang L; Li XC; Zhao JH; Qu Y; Zhu HT; Wang D; Cheng RR; Yang CR; Xu M; Zhang YJ
J Ethnopharmacol; 2015 Mar; 162():87-96. PubMed ID: 25555357
[TBL] [Abstract][Full Text] [Related]
16. BF061, a novel antiplatelet and antithrombotic agent targeting P2Y₁₂ receptor and phosphodiesterase.
Hu L; Fan Z; Du H; Ni R; Zhang S; Yin K; Ye J; Zhang Y; Wei X; Zhang X; Gross PL; Kunapuli SP; Ding Z
Thromb Haemost; 2011 Dec; 106(6):1203-14. PubMed ID: 21946947
[TBL] [Abstract][Full Text] [Related]
17. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity.
He JH; Guo SY; Zhu F; Zhu JJ; Chen YX; Huang CJ; Gao JM; Dong QX; Xuan YX; Li CQ
J Pharmacol Toxicol Methods; 2013; 67(1):25-32. PubMed ID: 23128142
[TBL] [Abstract][Full Text] [Related]
18. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
Herbert JM; Dol F; Bernat A; Falotico R; Lalé A; Savi P
Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636
[TBL] [Abstract][Full Text] [Related]
19. Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt model.
Mason RG; Wolf RH; Zucker WH; Shinoda BA; Mohammad SF
Am J Pathol; 1976 Jun; 83(3):557-68. PubMed ID: 820202
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
